Company intelligence / Profile preview

Medallion Therapeutics

Minneapolis-St. Paul or Valencia, Minnesota or California, United Stateslinkedin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Medallion Therapeutics is conducting pivotal clinical trials for its novel implantable infusion pump system designed for targeted and safe drug/biologic administration. The technology aims to address unmet needs in chronic diseases such as diabetes and neurodegenerative disorders, with expansion into additional indications like oncology. The company is preparing regulatory submissions for both US and European markets

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: DeviceBiologic (as a delivery target)Small molecule (as a delivery target)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Medallion Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medallion Therapeutics.

Explore the full profile